Melvin D. Yahr, MD - Publications

Affiliations: 
Mount Sinai School of Medicine New York University, New York, NY, United States 
Area:
Parkinson’s disease

191 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy. Parkinsonism & Related Disorders. 11: 151-5. PMID 15823479 DOI: 10.1016/j.parkreldis.2004.10.002  1
2004 Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1020-8. PMID 15372591 DOI: 10.1002/Mds.20213  1
2004 Gluck MR, Santana LA, Granson H, Yahr MD. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 713-24. PMID 15168218 DOI: 10.1007/s00702-004-0107-1  1
2003 Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation. 108: 724-8. PMID 12885750 DOI: 10.1161/01.CIR.0000083721.49847.D7  1
2003 Yahr MD, Orosz D, Purohit DP. Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings. Parkinsonism & Related Disorders. 9: 225-31. PMID 12618058 DOI: 10.1016/S1353-8020(02)00057-3  1
2003 Bhattacharya KF, Nouri S, Olanow CW, Yahr MD, Kaufmann H. Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension. Parkinsonism & Related Disorders. 9: 221-4. PMID 12618057 DOI: 10.1016/S1353-8020(02)00053-6  1
2002 Yahr MD. Gerald Cohen 1930-2001. Parkinsonism & Related Disorders. 8: 381-4. PMID 12356024  1
2002 Prikhojan A, Brannan T, Yahr MD. Intrastriatal iron perfusion releases dopamine: an in-vivo microdialysis study. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 645-9. PMID 12111456 DOI: 10.1007/s007020200053  1
2002 Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, Kaufmann H. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: A diagnostic algorithm Archives of Neurology. 59: 835-842. PMID 12020268  1
2001 Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 57: S11-26. PMID 11775596  1
2001 Werner P, Di Rocco A, Prikhojan A, Rempel N, Bottiglieri T, Bressman S, Yahr MD. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro. Brain Research. 893: 278-81. PMID 11223018 DOI: 10.1016/S0006-8993(00)03298-4  1
2000 Prikhojan A, Brannan T, Yahr MD. Comparative effects of repeated administration of dopamine agonists on circling behavior in rats. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1159-64. PMID 11129105 DOI: 10.1007/s007020070029  1
1999 Brannan T, Yahr MD. Focal tremor following striatal infarct--a case report. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 368-70. PMID 10091639 DOI: 10.1002/1531-8257(199903)14:2<368::AID-MDS1030>3.0.CO;2-0  1
1998 Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism--a review. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 645-76. PMID 9826109 DOI: 10.1007/s007020050086  1
1998 Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology. 51: 1057-62. PMID 9781529 DOI: 10.1212/WNL.51.4.1057  1
1998 Di Rocco A, Brannan T, Prikhojan A, Yahr MD. Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 247-51. PMID 9660102 DOI: 10.1007/s007020050053  1
1998 Brannan T, Prikhojan A, Yahr MD. Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation. Brain Research. 784: 148-53. PMID 9518585 DOI: 10.1016/S0006-8993(97)01191-8  1
1998 Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 50: 318 and 16 pages fol. PMID 9484345 DOI: 10.1212/WNL.50.2.318  1
1997 Brannan T, Prikhojan A, Yahr MD. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism. Journal of Neural Transmission (Vienna, Austria : 1996). 104: 77-87. PMID 9085195 DOI: 10.1007/BF01271296  1
1996 Brannan T, Prikhojan A, Yahr MD. An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1287-94. PMID 9013415  1
1996 Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalography and Clinical Neurophysiology. 100: 1-11. PMID 8964257 DOI: 10.1016/0168-5597(95)00169-7  1
1996 Molinari SP, Di Rocco A, Merchant C, Sen CN, Wolfe D, Yahr MD. An unusual sphenoid ridge tumor: cementifying fibroma. Journal of Neurology. 243: 103-4. PMID 8869398 DOI: 10.1007/Bf00878542  1
1996 Brannan T, Prikhojan A, Yahr MD. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat. Brain Research. 718: 165-8. PMID 8773780 DOI: 10.1016/0006-8993(96)00116-3  1
1996 Di Rocco A, Molinari SP, Kollmeier B, Yahr MD. Parkinson's disease: progression and mortality in the L-DOPA era. Advances in Neurology. 69: 3-11. PMID 8615142  1
1995 Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 10: 79-89. PMID 9620056 DOI: 10.1007/BF02251224  1
1995 Molinari SP, Sivakumar K, Corbin D, Yahr MD. Central neurocytoma: An unusual intraventricular tumor. The Mount Sinai Journal of Medicine, New York. 62: 436-8. PMID 8692158  1
1995 Molinari SP, Kaminski R, Di Rocco A, Yahr MD. The use of famotidine in the treatment of Parkinson's disease: a pilot study. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 243-7. PMID 8527008 DOI: 10.1007/BF02259665  1
1995 Merchant CA, Cohen G, Mytilineou C, DiRocco A, Moros D, Molinari S, Yahr MD. Human transplacental transfer of carbidopa/levodopa. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 239-42. PMID 8527007 DOI: 10.1007/BF02259664  1
1995 Bodis-Wollner I, Borod JC, Cicero B, Haywood CS, Raskin S, Mylin L, Sliwinski M, Falk A, Yahr MD. Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 197-209. PMID 8527004 DOI: 10.1007/BF02259661  1
1995 Brannan T, Yahr MD. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Annals of Neurology. 37: 95-8. PMID 7818264 DOI: 10.1002/ana.410370117  1
1994 Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/Mds.870090107  1
1994 Brannan T, Prikhojan A, Yahr MD. Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 8: 99-105. PMID 7893380 DOI: 10.1007/BF02250920  1
1994 Werner P, Mytilineou C, Cohen G, Yahr MD. Impaired oxidation of pyruvate in human embryonic fibroblasts after exposure to L-dopa. European Journal of Pharmacology. 263: 157-62. PMID 7821347 DOI: 10.1016/0014-2999(94)90536-3  1
1994 Mytilineou C, Werner P, Molinari S, Di Rocco A, Cohen G, Yahr MD. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 8: 223-8. PMID 7748465 DOI: 10.1007/BF02260943  1
1993 Yahr MD. Parkinson's disease. The L-dopa era. Advances in Neurology. 60: 11-7. PMID 8420128  1
1993 Yahr MD. Parkinson's disease: new approaches to diagnosis and treatment. Acta Neurologica Scandinavica. Supplementum. 146: 22-5. PMID 8333251  1
1993 Di Rocco A, Molinari S, Stollman AL, Decker A, Yahr MD. MRI abnormalities in Creutzfeldt-Jakob disease. Neuroradiology. 35: 584-5. PMID 8278035 DOI: 10.1007/BF00588398  1
1993 Brannan T, Martínez-Tica J, Yahr MD. Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: an in vivo study. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 6: 35-44. PMID 7692872 DOI: 10.1007/BF02252621  1
1993 Brannan T, Martínez-Tica J, Di Rocco A, Yahr MD. Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo study. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 6: 81-7. PMID 7509606 DOI: 10.1007/BF02261001  1
1992 Brannan T, Martínez-Tica J, Yahr MD. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats. Neurology. 42: 683-5. PMID 1549240 DOI: 10.1212/WNL.42.3.683  1
1992 Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 42: 590-3. PMID 1549219  1
1992 Brannan T, Martínez-Tica J, Yahr MD. Changes in body temperature markedly affect striatal dopamine release and metabolism: an in vivo study. Journal of Neural Transmission. General Section. 89: 193-6. PMID 1389003 DOI: 10.1007/BF01250671  1
1991 Brannan T, Martinez-Tica J, Yahr MD. Effect of long-term L-dopa administration on striatal extracellular dopamine release. Neurology. 41: 596-8. PMID 2011263  1
1991 Kaufmann H, Oribe E, Yahr MD. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 3: 143-8. PMID 1910486 DOI: 10.1007/BF02260889  1
1991 Elizan TS, Moros DA, Yahr MD. Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease. Experience in 26 patients receiving combined therapy for 26 months. Archives of Neurology. 48: 31-4. PMID 1898848 DOI: 10.1001/archneur.1991.00530130039017  1
1991 Brannan T, Martinez-Tica J, Yahr MD. Effect of dietary protein on striatal dopamine formation following L-dopa administration: an in vivo study. Neuropharmacology. 30: 1125-7. PMID 1758587 DOI: 10.1016/0028-3908(91)90143-Y  1
1991 Brannan T, Martinez-Tica J, Yahr MD. Effect of yohimbine on brain monoamines: an in vivo study. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 3: 81-7. PMID 1716906 DOI: 10.1007/BF02260883  1
1991 Issidorides MR, Mytilineou C, Panayotacopoulou MT, Yahr MD. Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 3: 49-61. PMID 1712207 DOI: 10.1007/BF02251136  1
1991 Brannan TS, Martinez J, Yahr MD. Re: L-Dopa in parkinson's disease Neurology. 41: 1709.  1
1990 Askenasy JJ, Yahr MD. Different laws govern motor activity in sleep than in wakefulness. Journal of Neural Transmission. General Section. 79: 103-11. PMID 2297394 DOI: 10.1007/BF01251005  1
1990 Raskin SA, Borod JC, Wasserstein J, Bodis-Wollner I, Coscia L, Yahr MD. Visuospatial orientation in Parkinson's disease. The International Journal of Neuroscience. 51: 9-18. PMID 2265914 DOI: 10.3109/00207459009000503  1
1990 Askenasy JJ, Yahr MD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 749-53. PMID 2246656  1
1990 Brannan T, Knott P, Kaufmann H, Yahr M. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa Advances in Neurology. 53: 75-81. PMID 2173378  1
1990 Kaufmann H, Oribe E, Pierotti AR, Roberts JL, Yahr MD. Atrial natriuretic factor in human autonomic failure. Neurology. 40: 1115-9. PMID 2141387 DOI: 10.1212/Wnl.40.7.1115  1
1990 Elizan TS, Yahr MD, Moros DA, Mendoza MR, Pang S, Bodian CA. L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients. Advances in Neurology. 53: 431-5. PMID 2122649  1
1990 Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 15-22. PMID 2113388 DOI: 10.1007/BF02251242  1
1990 Brannan T, Bhardwaj A, Yahr MD. L-threodops increases extracellular norepinephrine levels in the brain: an in vivo study. Neurology. 40: 1134-5. PMID 2113206 DOI: 10.1212/WNL.40.7.1134  1
1990 Pang S, Borod JC, Hernandez A, Bodis-Wollner I, Raskin S, Mylin L, Coscia L, Yahr MD. The auditory P 300 correlates with specific cognitive deficits in Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 249-64. PMID 2078307 DOI: 10.1007/BF02252920  1
1989 Brannan T, Knott P, Kaufmann H, Leung L, Yahr M. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPA Journal of Neural Transmission. 75: 149-157. PMID 2918307 DOI: 10.1007/BF01677428  1
1989 Yahr MD, Elizan TS, Moros D. Selegiline in the treatment of Parkinson's disease--long term experience. Acta Neurologica Scandinavica. Supplementum. 126: 157-61. PMID 2515721  1
1989 Elizan TS, Yahr MD, Moros DA, Mendoza MR, Pang S, Bodian CA. Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients. Archives of Neurology. 46: 1280-3. PMID 2511825 DOI: 10.1001/archneur.1989.00520480022013  1
1989 Elizan TS, Yahr MD, Moros DA, Mendoza MR, Pang S, Bodian CA. Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients. Archives of Neurology. 46: 1275-9. PMID 2511824 DOI: 10.1001/archneur.1989.00520480017012  1
1989 Lee DH, Mendoza M, Dvorozniak MT, Chung E, van Woert MH, Yahr MD. Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 1: 189-94. PMID 2505797 DOI: 10.1007/BF02248668  1
1988 Askenasy JJ, Yahr MD. Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated? Journal of Neural Transmission. 72: 67-76. PMID 3379388 DOI: 10.1007/BF01244633  1
1988 Dickoff DJ, Raps M, Yahr MD. Striatal syndrome following hyponatremia and its rapid correction. A manifestation of extrapontine myelinolysis confirmed by magnetic resonance imaging. Archives of Neurology. 45: 112-4. PMID 3337664 DOI: 10.1001/archneur.1988.00520250122033  1
1988 Wyszynski B, Yahr MD. An unusual concurrence of myotonia congenita and Wilson's disease. The Mount Sinai Journal of Medicine, New York. 55: 303-8. PMID 3266299  1
1988 Askenasy JJ, Yahr MD, Davidovitch S. Isolated phasic discharges in anterior tibial muscle: a stable feature of paradoxical sleep. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 5: 175-81. PMID 3250963  1
1988 Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology. 38: 951-6. PMID 2452997  1
1987 Askenasy JJ, Weitzman ED, Yahr MD. Are periodic movements in sleep a basal ganglia dysfunction? Journal of Neural Transmission. 70: 337-47. PMID 3681289 DOI: 10.1007/BF01253608  1
1987 Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain : a Journal of Neurology. 110: 1675-98. PMID 3427405 DOI: 10.1093/Brain/110.6.1675  1
1987 Yahr MD. R-(-)-deprenyl and parkinsonism. Journal of Neural Transmission. Supplementum. 25: 5-12. PMID 3123605  1
1987 Bergmann KJ, Mendoza MR, Yahr MD. Parkinson's disease and long-term levodopa therapy. Advances in Neurology. 45: 463-7. PMID 3103389  1
1986 Caroscio JT, Kochwa S, Sacks H, Makuku S, Cohen JA, Yahr MD. Quantitative cerebrospinal fluid IgG measurements as a marker of disease activity in multiple sclerosis. Archives of Neurology. 43: 1129-31. PMID 3778245 DOI: 10.1001/archneur.1986.00520110029009  1
1986 Marx M, Bodis-Wollner I, Bobak P, Harnois C, Mylin L, Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Research. 26: 185-93. PMID 3716211 DOI: 10.1016/0042-6989(86)90080-5  1
1986 Elizan TS, Sroka H, Maker H, Smith H, Yahr MD. Dementia in idiopathic Parkinson's disease. Variables associated with its occurrence in 203 patients. Journal of Neural Transmission. 65: 285-302. PMID 3086503 DOI: 10.1007/BF01249089  1
1986 Caroscio JT, Cohen JA, Zawodniak J, Takai V, Shapiro A, Blaustein S, Mulvihill MN, Loucas SP, Gudesblatt M, Rube D, Yahr MD. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis Neurology. 36: 141-145. PMID 3080693  1
1985 Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology. 35: 527-32. PMID 3982638 DOI: 10.1212/WNL.35.4.527  1
1984 Askenasy JJ, Yahr MD. Suppression of REM rebound by Pergolide. Journal of Neural Transmission. 59: 151-9. PMID 6726217 DOI: 10.1007/BF01255413  1
1984 Yahr MD. Limitations of long term use of antiparkinson drugs. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 191-4. PMID 6713316  1
1984 Plaitakis A, Berl S, Yahr MD. Neurological disorders associated with deficiency of glutamate dehydrogenase. Annals of Neurology. 15: 144-53. PMID 6703655 DOI: 10.1002/ana.410150206  1
1984 Bodis-Wollner I, Yahr MD, Mylin LH. Nonmotor functions of the basal ganglia. Advances in Neurology. 40: 289-98. PMID 6695605  1
1984 Clough CG, Bergmann KJ, Yahr MD. Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration. Advances in Neurology. 40: 131-40. PMID 6695589  1
1984 Cohen G, Pasik P, Cohen B, Leist A, Mytilineou C, Yahr MD. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys. European Journal of Pharmacology. 106: 209-10. PMID 6442232 DOI: 10.1016/0014-2999(84)90700-3  1
1984 Pasik P, Pasik T, Pecci-Saavedra J, Holstein GR, Yahr MD. Serotonin in pallidal neuronal circuits: an immunocytochemical study in monkeys. Advances in Neurology. 40: 63-76. PMID 6364733  1
1984 Kaufmann H, Elijovich F, Yahr MD. An unusual cause of tetany: surreptitious use of furosemide. The Mount Sinai Journal of Medicine, New York. 51: 625-8. PMID 6333628  1
1984 Moros DA, Yahr MD. Movement disorders in the psychiatric patient. Hospital & Community Psychiatry. 35: 377-83. PMID 6232196  1
1984 Plaitakis A, Berl S, Yahr MD. Alterations in glutamate metabolism in a form of olivo-ponto-cerebellar atrophy. International Journal of Neurology. 18: 25-39. PMID 6152906  1
1984 Bergmann KJ, Limongi JC, Lowe YH, Mendoza MR, Yahr MD. Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist. Lancet. 1: 559. PMID 6142265 DOI: 10.1016/S0140-6736(84)90947-4  1
1984 Caroscio JT, Cohen JA, Yahr MD, Kochwa S, Sacks H. In Reply Archives of Neurology. 41: 473. DOI: 10.1001/archneur.1984.04050170015004  1
1983 Elizan TS, Yahr MD. Histocompatibility antigens and postencephalitic Parkinsonism. Journal of Neurology, Neurosurgery, and Psychiatry. 46: 688. PMID 6886712 DOI: 10.1136/jnnp.46.7.688  1
1983 Caroscio JT, Kochwa S, Sacks H, Cohen JA, Yahr MD. Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An update. Archives of Neurology. 40: 409-13. PMID 6860176 DOI: 10.1001/archneur.1983.04050070039007  1
1983 Clough CG, Plaitakis A, Yahr MD. Oculogyric crises and parkinsonism. A case of recent onset. Archives of Neurology. 40: 36-7. PMID 6848086 DOI: 10.1001/archneur.1983.04050010056014  1
1983 Elizan TS, Casals J, Yahr MD. Antineurofilament antibodies in postencephalitic and idiopathic Parkinson's disease. Journal of the Neurological Sciences. 59: 341-7. PMID 6683749 DOI: 10.1016/0022-510X(83)90019-9  1
1983 Bronster DJ, Yahr MD. Hemiballism secondary to a metastatic neoplasm of the subthalamic nucleus as demonstrated by CT scan. The Mount Sinai Journal of Medicine, New York. 50: 351-5. PMID 6606128  1
1983 Yahr MD, Mendoza MR, Moros D, Bergmann KJ. Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline). Acta Neurologica Scandinavica. Supplementum. 95: 95-102. PMID 6428152  1
1983 Elizan TS, Maker H, Yahr MD. Neurotransmitter synthesizing enzymes in experimental viral encephalitis. Journal of Neural Transmission. 57: 139-47. PMID 6139411 DOI: 10.1007/BF01245114  1
1982 Diamond MS, Huang YP, Yahr MD. Sudden onset of involuntary movement disorders with arteriovenous malformations of the basal ganglia. The Mount Sinai Journal of Medicine, New York. 49: 438-42. PMID 6983658  1
1982 Wiesen M, Yahr MD, Krieger DT. Plasma beta-lipotropin levels in Parkinson's disease. Journal of Neural Transmission. 53: 75-82. PMID 6278076 DOI: 10.1007/BF01243521  1
1982 Bodis-Wollner I, Yahr MD, Mylin L, Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology. 11: 478-83. PMID 6125124 DOI: 10.1002/ana.410110507  1
1982 Plaitakis A, Berl S, Yahr MD. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science (New York, N.Y.). 216: 193-6. PMID 6121377  1
1981 Whetsell WO, Mytilineou C, Shen J, Yahr MD. The development of the dog nigrostriatal system in organotypic culture. Journal of Neural Transmission. 52: 149-61. PMID 7310391 DOI: 10.1007/BF01249600  1
1981 Clough CG, Mendoza M, Yahr MD. A case of sporadic juvenile Parkinson's disease. Archives of Neurology. 38: 730-1. PMID 7305708 DOI: 10.1001/archneur.1981.00510110090020  1
1981 Sroka H, Elizan TS, Yahr MD, Burger A, Mendoza MR. Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy. Archives of Neurology. 38: 339-42. PMID 7236060 DOI: 10.1001/archneur.1981.00510060041004  1
1981 Korczyn AD, Rubenstein AE, Yahr MD, Axelrod FB. The pupil in familial dysautonomia. Neurology. 31: 628-9. PMID 7194981  1
1981 Rubenstein AE, Mytilineoau C, Yahr MD, Revoltella RP. Neurological aspects of neurofibromatosis. Advances in Neurology. 29: 11-21. PMID 6798832  1
1981 Yahr MD. Early recognition of Parkinson's disease. Hospital Practice (Office Ed.). 16: 65-72, 77-80. PMID 6788672  1
1981 Rubenstein AE, Gudesblatt MS, Mytilineou C, Yahr MD. Acute autonomic neuropathy. International Journal of Neurology. 15: 279-92. PMID 6765481  1
1981 Rubenstein AE, Mytilineou C, Yahr MD, Pearson J, Goldstein M. Neurotransmitter analysis of dermal neurofibromas: implications for the pathogenesis and treatment of neurofibromatosis. Neurology. 31: 1184-8. PMID 6115338 DOI: 10.1212/WNL.31.9.1184  1
1981 Caroscio JT, Brannan T, Budabin M, Yahr MD, Huang YP. Siderosis and Subarachnoid Hemorrhage-Reply Archives of Neurology. 38: 67. DOI: 10.1001/archneur.1981.00510010093027  1
1980 Elizan TS, Terasaki PI, Yahr MD. HLA-B14 Antigen and Postencephalitic Parkinson's Disease: Their Association in an American-Jewish Ethnic Group Archives of Neurology. 37: 542-544. PMID 7417054 DOI: 10.1001/archneur.1980.00500580038004  1
1980 Duvoisin RC, Mendoza MM, Yahr MD. A comparative study of bromocriptine and levodopa in Parkinson's disease. Advances in Biochemical Psychopharmacology. 23: 271-5. PMID 7395618  1
1980 Caroscio JT, Brannan T, Budabin M, Huang YP, Yahr MD. Subarachnoid Hemorrhage Secondary to Spinal Arteriovenous Malformation and Aneurysm: Report of a Case and Review of the Literature Archives of Neurology. 37: 101-103. PMID 7356401 DOI: 10.1001/archneur.1980.00500510059011  1
1980 Rubenstein AE, Yahr MD, Mytilineou C, Sivak M, Mindel J, Frontera AT. Orthostatic hypotension in the Holmes-Adie syndrome Mount Sinai Journal of Medicine. 47: 57-61. PMID 6966749  1
1980 Caroscio JT, Yahr MD. Progressive myelopathy due to sarcoid Clinical Neurology and Neurosurgery. 82: 217-222. PMID 6263526 DOI: 10.1016/0303-8467(80)90012-8  1
1980 Plaitakis A, Whetsell WO, Cooper JR, Yahr MD. Chronic Leigh Disease: a genetic and biochemical study. Annals of Neurology. 7: 304-10. PMID 6246834 DOI: 10.1002/ana.410070404  1
1980 Winkler MH, Berl S, Whetsell WO, Yahr MD. Spiroperidol binding in the human caudate nucleus. Journal of Neural Transmission. Supplementum. 45-51. PMID 6159454  1
1980 Wasserman S, Yahr MD. Choreic Movements Induced by the use of Methadone Archives of Neurology. 37: 727-728. PMID 6108101 DOI: 10.1001/archneur.1980.00500600075016  1
1979 Elizan TS, Yahr MD, Casals J. Indirect immunofluorescence test against lymphocytic choriomeningitis (LCM) virus in Parkinson's disease Mount Sinai Journal of Medicine. 46: 597-598. PMID 393998  1
1979 Yahr MD. H. Houston Merritt, MD Jan 12, 1902—Jan 9, 1979 Archives of Neurology. 36: 185-186. PMID 371594 DOI: 10.1001/archneur.1979.00500400039003  1
1979 Elizan TS, Madden DL, Noble GR, Herrmann KL, Gardner J, Schwartz J, Smith H, Sever JL, Yahr MD. Viral antibodies in serum and CSF of Parkinsonian patients and controls. Archives of Neurology. 36: 529-34. PMID 224845 DOI: 10.1001/Archneur.1979.00500450023002  1
1978 Yahr MD. Overview of present day treatment of Parkinson's disease Journal of Neural Transmission. 43: 227-238. PMID 745015 DOI: 10.1007/BF01246959  1
1978 Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain : a Journal of Neurology. 101: 661-71. PMID 737524 DOI: 10.1093/brain/101.4.661  1
1978 Issidorides MR, Mytilineou C, Whetsell WO, Yahr MD. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain. Archives of Neurology. 35: 633-7. PMID 697603 DOI: 10.1001/Archneur.1978.00500340009002  1
1978 Elizan TS, Schwartz J, Yahr MD, Casals J. Antibodies Against Arboviruses in Postencephalitic and Idiopathic Parkinson's Disease Archives of Neurology. 35: 257-260. PMID 646678 DOI: 10.1001/archneur.1978.00500290003001  1
1978 Yahr MD. A Physician for All Seasons: James Parkinson 1755-1824 Archives of Neurology. 35: 185-188. PMID 346008 DOI: 10.1001/archneur.1978.00500280003001  1
1978 Rubenstein AE, Yahr MD, Mytilineou C, Bajaj K. Peripheral catecholamine depletion in amyloid autonomic neuropathy Mount Sinai Journal of Medicine. 45: 782-789. PMID 310959  1
1977 Shimizu N, Cohen B, Bala SP, Mendoza M, Yahr MD. Ocular dyskinesias in patients with Parkinson's disease treated with levodopa Annals of Neurology. 1: 167-171. PMID 889300  1
1977 Rubenstein AE, Yahr MD. Adult onset autonomic dysfunction coexistent with familial dysautonomia in a consanguineous family Neurology. 27: 168-170. PMID 556834  1
1977 Yahr MD. Parkinson's disease: overview of its current status Mount Sinai Journal of Medicine. 44: 183-191. PMID 301226  1
1977 Plaitakis A, Whetsell WO, Yahr MD. Subacute necrotizing encephalomyelopathy (Leigh's disease): clinical and genetic considerations of its adult form. Transactions of the American Neurological Association. 102: 32-6. PMID 210553  1
1977 Friedland R, Yahr MD. Meningoencephalopathy Secondary to Infectious Mononucleosis: Unusual Presentation With Stupor and Chorea Archives of Neurology. 34: 186-188. PMID 190986 DOI: 10.1001/Archneur.1977.00500150072014  1
1977 Yahr MD. George Cotzias Nature. 268: 779-780. DOI: 10.1038/268779a0  0.48
1977 Yahr MD, Friedland R. Acute Neurological Forms of Infectious Mononucleosis-Reply Archives of Neurology. 34: 651. DOI: 10.1001/archneur.1977.00500220085025  1
1977 Yahr MD, Rubenstein AE. Reply: Precision needed in medical reporting Neurology. 27: 798.  1
1976 Bowen FP, Burns MM, Brady EM, Yahr MD. A note on alterations of personal orientation in Parkinsonism Neuropsychologia. 14: 425-429. PMID 995236 DOI: 10.1016/0028-3932(76)90071-3  1
1976 Davis MJ, Cilo M, Plaitakis A, Yahr MD. Trichinosis: Severe myopathic involvement with recovery Neurology. 26: 37-40. PMID 942767 DOI: 10.1212/WNL.26.1.37  1
1976 Yahr MD. Parkinson's disease: Current concepts | ENFERMEDAD DE PARKINSON. CONCEPTOS ACTUALES Revista Neurologica Argentina. 2: 301-308.  1
1975 Yahr MD. Loss of peripheral noradrenergic mechanisms in familial dysautonomia | DER AUSFALL PERIPHERER NORADRENERGER MECHANISMEN BEI FAMILIARER DYSTROPHIE. EIN BERICHT UBER DIE BEZIEHUNGEN ZUR ORTHOSTATISCHEN HYPOTENSION Wiener Medizinische Wochenschrift. 125: 318-322. PMID 1216854  1
1975 Bowen FP, Kamienny RS, Burns MM, Yahr MD. Parkinsonism: Effects of levodopa treatment on concept formation Neurology. 25: 701-704. PMID 1171402 DOI: 10.1212/WNL.25.8.701  1
1975 Yahr MD. Summary report of the Joint Commission on Neurology Neurology. 25: 497-501. PMID 1168868  1
1975 Shimizu N, Weinberger J, Yahr MD. Downbeat nystagmus as a sign of brainstem involvement in acute meningoencephalitis. Neurology. 25: 267-70. PMID 1167635  1
1975 Yahr MD, Frontera AT. Acute Autonomic Neuropathy: Its Occurrence in Infectious Mononucleosis Archives of Neurology. 32: 132-133. PMID 1122177 DOI: 10.1001/archneur.1975.00490440082014  1
1975 Yahr MD. Levodopa Annals of Internal Medicine. 83: 677-682. PMID 128308  1
1974 Lobo Antunes J, Yahr MD, Hilal SK. Extrapyramidal dysfunction with cerebral arteriovenous malformations Journal of Neurology Neurosurgery and Psychiatry. 37: 259-268. PMID 4829531  1
1974 Yahr MD. Variations in the "on-off" effect Advances in Neurology. 5: 397-399. PMID 4440587  1
1974 Gamboa ET, Wolf A, Yahr MD, Harter DH, Duffy PE, Barden H, Hsu KC. Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence. Archives of Neurology. 31: 228-32. PMID 4370102 DOI: 10.1001/Archneur.1974.00490400042003  1
1974 Frigyesi TL, Yahr MD, Schwartz R. Electrophysiological analysis of the effects of L-Dopa on the reciprocal corticothalamic projections in the squirrel monkey - I. Iatrogenic coma and disinhibition of medial thalamic neurons Journal of Neural Transmission. 35: 151-173. PMID 4210679 DOI: 10.1007/BF01250742  1
1974 Yahr MD. Monoamines | NEUROLOGY; PROCEEDINGS OF THE 10TH INTERNATIONAL CONGRESS OF NEUROLOGY, BARCELONA, SEPTEMBER, 1973 Excerpta Medica, Amsterdam. p.49-p.55.  1
1973 Bowen FP, Brady E, Yahr MD. Sensorimotor coordination in parkinson’s disease before and after levodopa therapy Neurology. 23: 1101-1106. PMID 4795423  1
1973 Gamboa ET, Wolf A, Yahr MD, Barden H, Hsu CC, Duffy PE, Harter DH. Influenza A virus as a possible cause of postencephalitic Parkinsonism. Transactions of the American Neurological Association. 98: 177-80. PMID 4594185  1
1972 Bowen FP, Hoehn MM, Yahr MD. Parkinsonism: Alterations in spatial orientation as determined by a route-walking test Neuropsychologia. 10: 355-361. PMID 5080496 DOI: 10.1016/0028-3932(72)90027-9  1
1972 Yahr MD, Duvoisin RC. Pyridoxine and Levodopa in The Treatment of Parkinsonism Jama: the Journal of the American Medical Association. 220: 861. PMID 5067358 DOI: 10.1001/Jama.1972.03200060085023  1
1972 Proctor Bowen F, Hoehn MM, Yahr MD. Cerebral dominance in relation to tracking and tapping performance in patients with parkinsonism Neurology. 22: 32-39. PMID 5061837  1
1972 Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with postencephalitic Parkinsonism to levodopa Journal of Neurology Neurosurgery and Psychiatry. 35: 487-495. PMID 5049808 DOI: 10.1136/Jnnp.35.4.487  1
1972 Yamaguchi K, Tomasi L, Cote LJ, Barrett R, Yahr MD. Serotonin content of platelet enriched plasma in Parkinson patients prior and during treatment with L-3,4-dihydroxyphenylalanine (L-DOPA). Biochemical Medicine. 6: 210-5. PMID 5041890 DOI: 10.1016/0006-2944(72)90040-3  1
1972 Yahr MD, Lobo Antunes J. Relapsing Encephalomyelitis Following the Use of Influenza Vaccine Archives of Neurology. 27: 182-183. PMID 5040635 DOI: 10.1001/archneur.1972.00490140086012  1
1972 Yahr MD, Duvoisin RC, Côté L, Cohen G. Pyridoxine, DOPA, and Parkinsonism Advances in Biochemical Psychopharmacology. 4: 185-194. PMID 4555927  1
1972 Yahr MD, Duvoisin RC. Drug therapy of parkinsonism New England Journal of Medicine. 287: 20-24. PMID 4555145 DOI: 10.1056/Nejm197207062870105  1
1972 Duvoisin RC, Yahr MD. Epidemiological approach to Parkinson's disease. Lancet (London, England). 1: 1400-1. PMID 4113612 DOI: 10.1016/S0140-6736(72)91141-5  0.76
1972 Frigyesi TL, Rinvik E, Yahr MD. Corticothalamic Projections and Sensorimotor Activities Raven Press. 585 p.; $ 74.50/-.  1
1971 Yahr MD. Levodopa and parkinsonism: Clinical impressions Clinical Pharmacology and Therapeutics. 12: 332-334. PMID 5577481  1
1971 Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association. 96: 55-58. PMID 5159129  1
1971 Cote LJ, Cohen G, Yahr MD. The metabolism of orally administered L-dopa in Parkinson patients. Transactions of the American Neurological Association. 96: 222-3. PMID 5159086  1
1971 Yahr MD, Duvoisin RC. Pyridoxine, Levodopa, and L-α-Methyldopa Hydrazine Regimen in Parkinsonism Jama: the Journal of the American Medical Association. 216: 2141. DOI: 10.1001/Jama.1971.03180390051016  1
1970 Barrett RE, Yahr MD, Duvoisin RC. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa Neurology. 20: 107-113. PMID 5529472 DOI: 10.1212/Wnl.20.11_Part_2.107  1
1970 Yahr MD. Retrospect and prospect in neurology Transactions of the American Neurological Association. 95: 1-10. PMID 5514368 DOI: 10.1001/archneur.1970.00480300090012  1
1970 Cote L, Yahr MD, Duvoisin RC, Wolf A, Marksbery W. Analysis of deaths in Parkinson patients on long-term levodopa therapy Transactions of the American Neurological Association. 95: 73-77. PMID 4998770  1
1969 Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of Parkinsonism With Levodopa Archives of Neurology. 21: 343-354. PMID 5820999 DOI: 10.1001/Archneur.1969.00480160015001  1
1969 Duvoisin RC, Yahr MD, Coté LD. Pyridoxine reversal of L-dopa effects in Parkinsonism Transactions of the American Neurological Association. 94: 81-84. PMID 5374494  1
1968 Yahr MD. Discussion of 5-Hydroxyindoles and Migraine Advances in Pharmacology. 6: 201-202. PMID 5658322 DOI: 10.1016/S1054-3589(08)60316-6  1
1968 Yahr MD, Duvoisin RC. Medical therapy of Parkinsonism Modern Treatment. 5: 283-300. PMID 5655945  1
1968 Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism Transactions of the American Neurological Association. 93: 56-63. PMID 4885744  1
1967 Charlton MH, Yahr MD. Long-Term Follow-Up of Patients with Petit Mal Archives of Neurology. 16: 595-598. PMID 4961019 DOI: 10.1001/archneur.1967.00470240033003  1
1966 Boschenstein FK, Reilly JA, Yahr MD, Correll JW. Effect of Low Molecular Weight Dextran on Cortical Blood Flow Archives of Neurology. 14: 288-293. PMID 5905077 DOI: 10.1001/archneur.1966.00470090060008  1
1966 McMurtry JG, Yahr MD. Extracranial carotid artery occlusion by an anomalous digastric muscle Journal of Neurosurgery. 24: 108-110. PMID 5903294  1
1965 YAHR MD. SYMPOSIUM ON THE PATHOPHYSIOLOGY AND TREATMENT OF BASAL GANGLIA DISEASES Bulletin of the New York Academy of Medicine. 41: 855-857. PMID 14320526  1
1965 Duvoisin RC, Yahr MD. Posterior fossa aneurysms Neurology. 15: 231-241. PMID 14262321 DOI: 10.1212/Wnl.15.3.231  1
1965 Duvoisin RC, Yahr MD. Encephalitis and Parkinsonism Archives of Neurology. 12: 227-239. PMID 14247380 DOI: 10.1001/Archneur.1965.00460270003001  1
1965 Yahr MD, Duvoisin RC, Cowen D. Encephalopathy associated with carcinoma. Transactions of the American Neurological Association. 90: 80-6. PMID 5857782  1
1965 Roizin L, Iyengar VK, Marquezàlba E, Yahr MD. Correlated neuropathologic and cyto-enzymatic studies following atropine administration. Transactions of the American Neurological Association. 90: 281-2. PMID 5857762  1
1965 Yahr MD. Biochemistry and pharmacology of the basal ganglia Neuropharmacology. 4: 393-394.  1
1964 HARTER DH, YAHR MD. CEREBROSPINAL FLUID CHANGES IN MENINGITIS International Journal of Neurology. 4: 113-122. PMID 14296897  1
1964 Dominique Allerand C, Yahr MD. Gamma-globulin affinity for normal human tissue of the central nervous system Science. 144: 1141-1142. PMID 14148436  1
1963 DUVOISIN RC, YAHR MD, SCHWEITZER MD, MERRITT HH. PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA. Archives of Neurology. 9: 232-6. PMID 14049396 DOI: 10.1001/Archneur.1963.00460090038003  1
1962 HARTER DH, YAHR MD, KABAT EA. Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review Transactions of the American Neurological Association. 87: 210-212. PMID 13953079  1
1962 Duvoisin RC, Yahr MD. Compressive spinal cord and root syndromes in achondroplastic dwarfs Neurology. 12: 202-207. PMID 13888761 DOI: 10.1212/Wnl.12.3.202  1
1961 POTANOS J, YAHR MD. Cerebrovascular occlusion secondary to metastatic tumors of the brain Transactions of the American Neurological Association. 86: 140-146. PMID 14488250  1
1960 YAHR MD. Winchell McK. CRAIG, 1892-1960 Transactions of the American Neurological Association. 85: 260-262. PMID 14038098  1
1960 TRIEDMAN HM, FISHMAN RA, YAHR MD. Determination of plasma and cerebrospinal fluid levels of dilantin in the human Transactions of the American Neurological Association. 85: 166-170. PMID 13922470  1
1956 YAHR MD, MERRITT HH. Current status of the drug therapy of epileptic seizures. Journal of the American Medical Association. 161: 333-8. PMID 13318923 DOI: 10.1001/Jama.1956.62970040010009  0.32
1952 YAHR MD, SCIARRA D, CARTER S, MERRITT HH. Evaluation of standard anticonvulsant therapy in three hundred nineteen patients. Journal of the American Medical Association. 150: 663-7. PMID 12980818 DOI: 10.1001/Jama.1952.03680070033009  0.32
Show low-probability matches.